ATE369864T1 - Diätetisches kalzium als ergänzung zu vitamin d verbindungen bei der behandlung von multipler sklerose - Google Patents

Diätetisches kalzium als ergänzung zu vitamin d verbindungen bei der behandlung von multipler sklerose

Info

Publication number
ATE369864T1
ATE369864T1 AT00941671T AT00941671T ATE369864T1 AT E369864 T1 ATE369864 T1 AT E369864T1 AT 00941671 T AT00941671 T AT 00941671T AT 00941671 T AT00941671 T AT 00941671T AT E369864 T1 ATE369864 T1 AT E369864T1
Authority
AT
Austria
Prior art keywords
multiple sclerosis
vitamin
supplement
compounds
treatment
Prior art date
Application number
AT00941671T
Other languages
English (en)
Inventor
Hector Deluca
Margherite Cantorna
Jean Humpal-Winter
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE369864T1 publication Critical patent/ATE369864T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00941671T 1999-07-08 2000-06-23 Diätetisches kalzium als ergänzung zu vitamin d verbindungen bei der behandlung von multipler sklerose ATE369864T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/349,528 US6479474B2 (en) 1999-07-08 1999-07-08 Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
ATE369864T1 true ATE369864T1 (de) 2007-09-15

Family

ID=23372774

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00941671T ATE369864T1 (de) 1999-07-08 2000-06-23 Diätetisches kalzium als ergänzung zu vitamin d verbindungen bei der behandlung von multipler sklerose

Country Status (8)

Country Link
US (3) US6479474B2 (de)
EP (1) EP1196174B1 (de)
JP (1) JP2003504337A (de)
AT (1) ATE369864T1 (de)
AU (1) AU5634500A (de)
DE (1) DE60035996T2 (de)
DK (1) DK1196174T3 (de)
WO (1) WO2001003704A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060189532A1 (en) * 2005-02-14 2006-08-24 Deluca Hector F Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
US7566696B2 (en) * 2002-09-05 2009-07-28 Wisconsin Alumni Research Foundation Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
WO2004076468A1 (ja) 2003-02-25 2004-09-10 Kobe Tennenbutsu Kagaku Kabushiki Kaisha ビタミンｄ誘導体を合成するための新規な中間体
CA2518079A1 (en) * 2003-03-04 2004-10-28 Teva Pharmaceutical Industries, Ltd. Combination therapy with glatiramer acetate and alphacalcidol for the treatment of multiple sclerosis
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
EP1656157B1 (de) * 2003-08-20 2011-12-21 Wisconsin Alumni Research Foundation 2-methylen-19-nor-vitamin d2-verbindungen
US20050080109A1 (en) * 2003-10-09 2005-04-14 Papas Andreas M. Gamma-tocopherol and gamma-tocotrienol therapy for multiple sclerosis
US20060194185A1 (en) * 2005-02-10 2006-08-31 David Goldberg Information request system and method
WO2006086608A1 (en) * 2005-02-11 2006-08-17 Wisconsin Alumni Research Foundation 2-METHYLENE-19-NOR-(20S-24EPI)-1α,25-DIHYDROXYVITAMIN-D2
US7563783B2 (en) * 2005-02-11 2009-07-21 Wisconsin Alumni Research Foundation 2-methylene-19-nor-(20S-24S)-1α,25-dihydroxyvitamin-D2
EP1931390B1 (de) * 2005-10-05 2012-07-25 Bayhill Therapeutics, Inc. Zusammensetzungen und verfahren zur behandlung von autoimmunkrankheit
CA2655357A1 (en) * 2006-06-13 2007-12-21 Bayhill Therapeutics, Inc. Polynucleotide therapy
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279826A (en) 1980-09-22 1981-07-21 Wisconsin Alumni Research Foundation 23,25-Dihydroxyvitamin D3
US4307025A (en) 1981-02-17 1981-12-22 Wisconsin Alumni Research Foundation 1α, 25-dihydroxy-2β-fluorovitamin D3
US4448721A (en) 1982-09-20 1984-05-15 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 compounds and process for preparing same
US5036061A (en) 1983-05-09 1991-07-30 Deluca Hector F Process for the preparation of 1 alpha,25-dihydroxylated vitamin D2 and related compounds
US4500460A (en) 1983-08-18 1985-02-19 Wisconsin Alumni Research Foundation 23,23-Difluoro-25-hydroxy-vitamin D3 and process for preparing same
US4502991A (en) 1983-08-18 1985-03-05 Wisconsin Alumni Research Foundation 23,23-Difluoro-1α,25-dihydroxy-vitamin D3
US4769181A (en) 1983-11-07 1988-09-06 Wisconsin Alumni Research Foundation 1,25-dihydroxyvitamin D2 compounds
US4505906A (en) 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US4588528A (en) 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4594192A (en) 1985-03-20 1986-06-10 Wisconsin Alumni Research Foundation 2α-fluorovitamin D3
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US4619920A (en) 1985-09-16 1986-10-28 Wisconsin Alumni Research Foundation 26,26,26,27,27-pentafluoro-1α-hydroxy-27-methoxyvitamin D3
JPS63104926A (ja) 1986-10-21 1988-05-10 Teijin Ltd 老年性痴呆症治療又は予防剤
US4973584A (en) 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
CA1333616C (en) 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
US5030772A (en) 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
US5260290A (en) 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
JP2845342B2 (ja) 1990-04-28 1999-01-13 大正製薬株式会社 ビタミンｄ▲下３▼誘導体含有固形製剤組成物
HUT66379A (en) 1991-05-28 1994-11-28 Procter & Gamble Calcium, trace mineral, vitamin d and drug therapy combinations
US5260199A (en) 1991-07-30 1993-11-09 Wisconsin Alumni Research Foundation Method of producing 1,25-dihydroxyvitamin D3 receptor protein
DE69214617T2 (de) 1991-12-26 1997-05-28 Wisconsin Alumni Res Found 26,27-Dimethylen-1-Alpha, 25-Dihydroxyvitamin-D2 und 26,27-Dihydroxyvitamin-D2 und Verfahren zu ihrer Herstellung
AU666529B2 (en) 1992-04-24 1996-02-15 Wisconsin Alumni Research Foundation Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
TW272187B (de) 1992-05-20 1996-03-11 Hoffmann La Roche
ES2091515T3 (es) 1992-05-20 1996-11-01 Hoffmann La Roche Analogos fluorados de la vitamina d3.
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
US5371249A (en) 1993-05-11 1994-12-06 Wisconsin Alumni Research Foundation Iodo vitamin D3 compounds and method for preparing same
US5380720A (en) 1993-05-11 1995-01-10 Wisconsin Alumni Research Foundation Iodo vitamin D3 compounds and method for preparing same
WO1995001960A1 (en) 1993-07-09 1995-01-19 Laboratoire Theramex S.A. Novel structural analogues of vitamin d
US5373004A (en) 1993-11-24 1994-12-13 Wisconsin Alumni Research Foundation 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
US5716946A (en) 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
DE19710054A1 (de) 1997-03-12 1998-09-17 Merck Patent Gmbh Pharmazeutische Zubereitung
AU732331B2 (en) 1997-04-28 2001-04-12 F. Hoffmann-La Roche Ag Vitamin D3 analogs with bis C-20 side chains
WO1998051678A1 (en) 1997-05-16 1998-11-19 Women & Infants Hospital CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
US6673782B2 (en) 1999-04-29 2004-01-06 Wisconsin Alumni Research Foundation Treatment of systemic lupus erythematosis

Also Published As

Publication number Publication date
WO2001003704A1 (en) 2001-01-18
DK1196174T3 (da) 2007-12-27
US20030022873A1 (en) 2003-01-30
US20030207847A1 (en) 2003-11-06
JP2003504337A (ja) 2003-02-04
DE60035996D1 (de) 2007-09-27
US20020016313A1 (en) 2002-02-07
EP1196174B1 (de) 2007-08-15
AU5634500A (en) 2001-01-30
EP1196174A1 (de) 2002-04-17
US6479474B2 (en) 2002-11-12
DE60035996T2 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
ATE369864T1 (de) Diätetisches kalzium als ergänzung zu vitamin d verbindungen bei der behandlung von multipler sklerose
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
DE69837324D1 (de) Behandlung der multiplen sklerose durch einnahme von copolymer-1
ATE359806T1 (de) Nachweis und therapie von empfindlichem plaque mit photodynamischen verbindungen
NO20052494L (no) Preparater inneholdende melatonin, gingko biloba og biotin.
PT966465E (pt) Inibidores do enzima imfdh
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
ATE344029T1 (de) Behandlung von typ ii diabetes mit dipeptidyl- peptidase-iv-hemmern
EA200700362A1 (ru) Конъюгат, содержащий антивирусное соединение, в частности ингибирующее вич, фармацевтическая композиция и набор стандартной дозы лекарственного препарата на его основе, способ ингибирования с его помощью
ATE530167T1 (de) Kombinierte dosierform mit einem cholesterinsenker, einem renin-angiotensin-hemmer und acetylsalicylsäure
NO20002605L (no) Sferoider, fremstillingsmetode og farmasøytiske sammensetninger
TR200003801T2 (tr) Acı hafifletmek için deri üstü kompozisyonlar ve yöntemler
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
ATE400258T1 (de) Transdermales buprenorphin-dosierschema zwecks schmerzstillung
NO962841D0 (no) Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
DE60019334D1 (de) Antivirale arznei
DE69905878T2 (de) Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen
EE200400031A (et) Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat
ATE312815T1 (de) Neue verbindungen
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
IS6675A (is) Amínóalkoxýbensóýl-bensófúran eða bensóþíófenafleiður, aðferð til framleiðslu þeirra og samsetningar sem innihalda þær
DE50109650D1 (de) Topische behandlung bei der mastalgie
WO2001091796A8 (en) Methods, compounds and compositions for treating gout

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1196174

Country of ref document: EP

REN Ceased due to non-payment of the annual fee